Chesnara (LON:CSN) Hits New 52-Week High – Time to Buy?

Chesnara plc (LON:CSN)’s stock price reached a new 52-week high on Wednesday . The company traded as high as GBX 352 and last traded at GBX 349.50, with a volume of 1016872 shares. The stock had previously closed at GBX 339.50.

Key Headlines Impacting Chesnara

Here are the key news stories impacting Chesnara this week:

• Positive Sentiment: HSBC Life acquisition lifts scale and profits: Reports say assets under administration increased by 38% following the deal, while first-half profits were boosted by the acquired business. The transaction appears to be contributing meaningfully to Chesnara’s earnings and strategic scale. Chesnara reports 38% boost in AuA after HSBC Life acquisition Chesnara’s H1 profits surge as results boosted by HSBC deal
• Positive Sentiment: Cash generation strengthens materially: Operating capital generation reportedly approached £100 million, including a 79% year-on-year increase. The improvement strengthens Chesnara’s ability to fund dividends, reduce financial pressure and pursue additional acquisitions. Chesnara’s operating capital generation nears £100m following acquisition Chesnara CEO: 79% jump in capital generation fuels acquisition ambitions
• Positive Sentiment: Dividend increased: Chesnara raised its dividend alongside the stronger results and cash generation, reinforcing the income-investment appeal of the stock. Brokers have reportedly backed the acquisition-driven cash-growth outlook. Chesnara Reports Stronger Cash Generation and Raises Dividend Following HSBC Life Acquisition Chesnara shares climb as brokers back acquisition-driven cash growth
• Positive Sentiment: Underlying product demand remains encouraging: Chesnara reported surging demand for UK onshore bonds, suggesting supportive market conditions for a key area of its business. Chesnara reports surging demand for UK onshore bonds
• Neutral Sentiment: Key issue for investors: Management’s ambitions for further acquisitions could support future growth, but investors will likely monitor integration execution and whether additional deals deliver returns comparable with the HSBC Life transaction.

Analysts Set New Price Targets

Separately, Berenberg Bank boosted their target price on shares of Chesnara from GBX 373 to GBX 404 and gave the company a “buy” rating in a research report on Friday, July 24th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of GBX 382.

Chesnara Price Performance

The company has a quick ratio of 38.06, a current ratio of 2.92 and a debt-to-equity ratio of 49.41. The company has a market capitalization of £810.91 million, a price-to-earnings ratio of -69.60 and a beta of 0.52. The stock’s 50-day simple moving average is GBX 335.21 and its two-hundred day simple moving average is GBX 319.55.

Chesnara (LON:CSN) last announced its earnings results on Tuesday, August 25th. The company reported GBX 0.22 earnings per share (EPS) for the quarter. Chesnara had a negative net margin of 1.01% and a negative return on equity of 2.93%. Equities research analysts predict that Chesnara plc will post 25.3183154 earnings per share for the current year.

Chesnara Company Profile

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.